146 related articles for article (PubMed ID: 25511705)
1. Crystal structure of the polo-box domain of polo-like kinase 2.
Shan HM; Wang T; Quan JM
Biochem Biophys Res Commun; 2015 Jan; 456(3):780-4. PubMed ID: 25511705
[TBL] [Abstract][Full Text] [Related]
2. The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.
Elia AE; Rellos P; Haire LF; Chao JW; Ivins FJ; Hoepker K; Mohammad D; Cantley LC; Smerdon SJ; Yaffe MB
Cell; 2003 Oct; 115(1):83-95. PubMed ID: 14532005
[TBL] [Abstract][Full Text] [Related]
3. Structure and function of Polo-like kinases.
Lowery DM; Lim D; Yaffe MB
Oncogene; 2005 Jan; 24(2):248-59. PubMed ID: 15640840
[TBL] [Abstract][Full Text] [Related]
4. Polo-box domains confer target specificity to the Polo-like kinase family.
van de Weerdt BC; Littler DR; Klompmaker R; Huseinovic A; Fish A; Perrakis A; Medema RH
Biochim Biophys Acta; 2008 Jun; 1783(6):1015-22. PubMed ID: 18359294
[TBL] [Abstract][Full Text] [Related]
5. Development of high-throughput assays based on fluorescence polarization for inhibitors of the polo-box domains of polo-like kinases 2 and 3.
Reindl W; Gräber M; Strebhardt K; Berg T
Anal Biochem; 2009 Dec; 395(2):189-94. PubMed ID: 19716361
[TBL] [Abstract][Full Text] [Related]
6. Structural analysis of the polo-box domain of human Polo-like kinase 2.
Kim JH; Ku B; Lee KS; Kim SJ
Proteins; 2015 Jul; 83(7):1201-8. PubMed ID: 25846005
[TBL] [Abstract][Full Text] [Related]
7. The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localization.
Leung GC; Hudson JW; Kozarova A; Davidson A; Dennis JW; Sicheri F
Nat Struct Biol; 2002 Oct; 9(10):719-24. PubMed ID: 12352953
[TBL] [Abstract][Full Text] [Related]
8. The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex.
Cheng KY; Lowe ED; Sinclair J; Nigg EA; Johnson LN
EMBO J; 2003 Nov; 22(21):5757-68. PubMed ID: 14592974
[TBL] [Abstract][Full Text] [Related]
9. Phosphatase-Stable Phosphoamino Acid Mimetics That Enhance Binding Affinities with the Polo-Box Domain of Polo-like Kinase 1.
Hymel D; Burke TR
ChemMedChem; 2017 Feb; 12(3):202-206. PubMed ID: 27992122
[TBL] [Abstract][Full Text] [Related]
10. A high-throughput assay based on fluorescence polarization for inhibitors of the polo-box domain of polo-like kinase 1.
Reindl W; Strebhardt K; Berg T
Anal Biochem; 2008 Dec; 383(2):205-9. PubMed ID: 18793607
[TBL] [Abstract][Full Text] [Related]
11. Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.
Yun SM; Moulaei T; Lim D; Bang JK; Park JE; Shenoy SR; Liu F; Kang YH; Liao C; Soung NK; Lee S; Yoon DY; Lim Y; Lee DH; Otaka A; Appella E; McMahon JB; Nicklaus MC; Burke TR; Yaffe MB; Wlodawer A; Lee KS
Nat Struct Mol Biol; 2009 Aug; 16(8):876-82. PubMed ID: 19597481
[TBL] [Abstract][Full Text] [Related]
12. Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization.
García-Alvarez B; de Cárcer G; Ibañez S; Bragado-Nilsson E; Montoya G
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3107-12. PubMed ID: 17307877
[TBL] [Abstract][Full Text] [Related]
13. Rational Molecular Design of Potent PLK1 PBD Domain-binding Phosphopeptides Using Preferential Amino Acid Building Blocks.
Mao XL; Wang KF; Zhu F; Pan ZH; Wu GM; Zhu HY
Chem Biodivers; 2016 Aug; 13(8):1103-10. PubMed ID: 27450535
[TBL] [Abstract][Full Text] [Related]
14. Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors.
Zhao XZ; Tsuji K; Hymel D; Burke TR
Molecules; 2019 Apr; 24(8):. PubMed ID: 31014020
[TBL] [Abstract][Full Text] [Related]
15. Plk1 activation by Ste20-like kinase (Slk) phosphorylation and polo-box phosphopeptide binding assayed with the substrate translationally controlled tumor protein (TCTP).
Johnson TM; Antrobus R; Johnson LN
Biochemistry; 2008 Mar; 47(12):3688-96. PubMed ID: 18298087
[TBL] [Abstract][Full Text] [Related]
16. A case study from the chemistry core of the Pittsburgh Molecular Library Screening Center: the Polo-like kinase polo-box domain (Plk1-PBD).
Wipf P; Arnold D; Carter K; Dong S; Johnston PA; Sharlow E; Lazo JS; Huryn D
Curr Top Med Chem; 2009; 9(13):1194-205. PubMed ID: 19807663
[TBL] [Abstract][Full Text] [Related]
17. Development of Bifunctional Inhibitors of Polo-Like Kinase 1 with Low-Nanomolar Activities Against the Polo-Box Domain.
Scharow A; Knappe D; Reindl W; Hoffmann R; Berg T
Chembiochem; 2016 Apr; 17(8):759-67. PubMed ID: 26634982
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel peptidomimetics targeting the polo-box domain of polo-like kinase 1.
Li Z; Zhang Z; Sun H; Xu L; Jiang C
Bioorg Chem; 2019 Oct; 91():103148. PubMed ID: 31376784
[TBL] [Abstract][Full Text] [Related]
19. Effects on polo-like kinase 1 polo-box domain binding affinities of peptides incurred by structural variation at the phosphoamino acid position.
Qian W; Park JE; Liu F; Lee KS; Burke TR
Bioorg Med Chem; 2013 Jul; 21(14):3996-4003. PubMed ID: 22743087
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of d-amino acid-containing peptidomimetics targeting the polo-box domain of polo-like kinase 1.
Li Z; Zhang Z; Chen Y; Tang S; Lin T; Huang J; Li B; Jiang C
Bioorg Chem; 2019 Apr; 85():534-540. PubMed ID: 30807896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
